<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropharmacology</journal-id><journal-id journal-id-type="iso-abbrev">Neuropharmacology</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Neuropharmacology</journal-title></journal-title-group><issn pub-type="ppub">0028-3908</issn><issn pub-type="epub">1873-7064</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11195011</article-id><article-id pub-id-type="pmcid-ver">PMC11195011.319</article-id><article-id pub-id-type="pmcaid">11195011</article-id><article-id pub-id-type="pmcaiid">11195011</article-id><article-id pub-id-type="manuscript-id">NIHMS1998652</article-id><article-id pub-id-type="pmid">38754577</article-id><article-id pub-id-type="doi">10.1016/j.neuropharm.2024.110002</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1998652</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1998652</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Assessment of the Antinociceptive, Respiratory-Depressant, and Reinforcing Effects of the Low pK<sub>a</sub> Fluorinated Fentanyl Analogs, FF3 and NFEPP</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Edwards</surname><given-names initials="SR">Shelley R.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blough</surname><given-names initials="BE">Bruce E.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cowart</surname><given-names initials="K">Kristian</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Howell</surname><given-names initials="GH">Grace H.</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Araujo</surname><given-names initials="AA">Aaron A.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Haskell</surname><given-names initials="JP">Jacob P.</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huskinson</surname><given-names initials="SL">Sally L.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rowlett</surname><given-names initials="JK">James K.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brackeen</surname><given-names initials="MF">Marcus F.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Freeman</surname><given-names initials="KB">Kevin B.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A6" ref-type="aff">6</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216</aff><aff id="A2"><label>2</label>RTI International, Research Triangle Park, NC 27709</aff><aff id="A3"><label>3</label>Utrecht University, Heidelberglaan 8, 3548 CS Utrecht</aff><aff id="A4"><label>4</label>School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216</aff><aff id="A5"><label>5</label>Program in Neuroscience, University of Mississippi Medical Center, Jackson, MS 39216</aff><aff id="A6"><label>6</label>Center for Innovation and Discovery in Addiction, University of Mississippi Medical Center, Jackson, MS 39216</aff><author-notes><corresp id="CR1"><bold>Address all correspondence to:</bold> Shelley R. Edwards, Program in Neuroscience, School of Graduate Studies in Health Sciences, University of Mississippi Medical Center, 2500 N. State Street, <email>Sredwards@umc.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P42"><bold>Declarations of interest:</bold> none</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>14</day><month>5</month><year>2024</year></pub-date><volume>255</volume><issue-id pub-id-type="pmc-issue-id">465292</issue-id><fpage>110002</fpage><lpage>110002</lpage><pub-history><event event-type="nihms-submitted"><date><day>08</day><month>06</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-25 10:25:12.947"><day>25</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1998652.pdf"/><abstract id="ABS1"><sec id="S1"><title>Rationale:</title><p id="P1">Recent studies report that fentanyl analogs with relatively low pK<sub>a</sub> values produce antinociception in rodents without other mu opioid-typical side effects due to the restriction of their activity to injured tissue with relatively low pH values. However, it is unclear if and to what degree these compounds may produce mu opioid-typical side effects (respiratory depression, reinforcing effects) at doses higher than those required to produce antinociception.</p></sec><sec id="S2"><title>Objectives:</title><p id="P2">The present study compared the inflammatory antinociceptive, respiratory-depressant, and reinforcing effects of fentanyl and two analogs of intermediate (FF3) and low (NFEPP) pK<sub>a</sub> values in terms of potency and efficacy in male and female Sprague-Dawley rats.</p></sec><sec id="S3"><title>Methods:</title><p id="P3">Nociception was produced by administration of Complete Freund&#8217;s Adjuvant into the hind paw of subjects, and antinociception was measured using an electronic Von Frey test. Respiratory depression was measured using whole-body plethysmography. Reinforcing effects were measured in self-administration using a progressive-ratio schedule of reinforcement. The dose ranges tested for each drug encompassed no effect to maximal effects.</p></sec><sec id="S4"><title>Results:</title><p id="P4">All compounds produced full effects in all measures but varied in potency. FF3 and fentanyl were equipotent in antinociception and self-administration, but FF3 was less potent than fentanyl in respiratory depression. NFEPP was less potent than fentanyl in every measure. The magnitude of potency difference between antinociception and other effects was greater for FF3 than for NFEPP or fentanyl, indicating that FF3 had the widest margin of safety when relating antinociception to respiratory-depressant and reinforcing effects.</p></sec><sec id="S5"><title>Conclusions:</title><p id="P5">Low pK<sub>a</sub> fentanyl analogs possess potential as safer analgesics, but determining the optimal degree of difference for pK<sub>a</sub> relative to fentanyl will require further study due to some differences between the current results and findings from prior work with these analogs.</p></sec></abstract><abstract id="ABS2" abstract-type="graphical"><title>Graphical Abstract</title><p id="P6">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="nihms-1998652-f0001.jpg"/>
</p></abstract><kwd-group><kwd>fentanyl</kwd><kwd>self-administration</kwd><kwd>respiratory depression</kwd><kwd>antinociception</kwd><kwd>fentanyl analogs</kwd><kwd>pKa</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>